Onesano S.A. Logo

Onesano S.A.

Develops patented nutritional products for humans, animals, and agriculture.

SKT | WAR

Overview

Corporate Details

ISIN(s):
PLSKTAN00010 (+1 more)
LEI:
259400O0ENJE93KANI38
Country:
Poland
Address:
CHORZÓW DYREKCYJNA 6, 41-506 CHORZÓW
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Onesano S.A. is a Polish biotechnology company specializing in the research, development, and production of innovative products for the full nutritional cycle. The company's portfolio includes natural dietary supplements for humans, animal nutrition products, and solutions for agriculture. Leveraging its own R&D laboratories and two production plants, Onesano develops proprietary, patented formulas and offers private label manufacturing services. The company, formerly known as Skotan S.A., operates an extensive distribution network and is committed to creating solutions that support human and planetary health through science-backed products.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 21:12
Legal Proceedings Report
Aktualizacja informacji dotyczących zwrotu środków pochodzących z umowy o dofin…
Polish 2.1 KB
2025-09-04 18:30
Legal Proceedings Report
Aktualizacja informacji dotyczących zwrotu środków pochodzących z umowy o dofin…
Polish 1.2 KB
2025-09-03 20:48
Legal Proceedings Report
Aktualizacja informacji dotyczących zwrotu środków pochodzących z umowy o dofin…
Polish 2.7 KB
2025-08-14 17:20
Interim Report
onesano_SA_raport_polroczny_IH2025
Polish 2.3 MB
2025-08-14 17:20
Audit Report / Information
RAPORT_przegląd_IH2025
Polish 241.4 KB
2025-08-11 21:43
Registration Form
Statut_onesano_SA_po_rejestracji_w_dn.11.08.2025
Polish 515.2 KB
2025-08-11 21:43
Governance Information
Rejestracja zmian Statutu Spółki - Content (PL)
Polish 6.7 KB
2025-06-30 18:17
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy dysponujących co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 539 bytes
2025-06-30 18:07
Board/Management Information
Życiorys-członka-RN-onesano-JBlaszczak
Polish 278.7 KB
2025-06-30 18:07
Board/Management Information
Powołanie osoby nadzorującej - Content (PL)
Polish 2.2 KB
2025-06-30 17:55
Registration Form
onesano_Zalacznik_do_uchwaly_nr_18_ZWZ_30.06.2025
Polish 515.1 KB
2025-06-30 17:55
Remuneration Information
onesano_Sprawozdanie_Rady_Nadzorczej_o_wynagrodzeniach_za_2024r.
Polish 1.2 MB
2025-06-30 17:55
Board/Management Information
onesano_Sprawozdanie_RN_z_dzialalnosci_w_2024r.
Polish 1.3 MB
2025-06-30 17:55
Post-Annual General Meeting Information
onesano_Uchwaly_ZWZ_30.06.2025
Polish 528.0 KB
2025-06-30 17:55
Post-Annual General Meeting Information
Uchwały podjęte przez Zwyczajne Walne Zgromadzenie onesano S.A. w dniu 30 czerw…
Polish 911 bytes

Automate Your Workflow. Get a real-time feed of all Onesano S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Onesano S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Onesano S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ChoA Pharmaceutical Co., LTD. Logo
Global manufacturer of OTC medicines and health supplements distributed through pharmacies.
South Korea 034940
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan 4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden CINPHA
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway CRNA
CJ Bioscience Logo
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
South Korea 311690
CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea 063160
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea 058820
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany CNW
Compugen Ltd. Logo
Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.
Israel CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.
South Korea 166480

Talk to a Data Expert

Have a question? We'll get back to you promptly.